These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 7756664

  • 1. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
    Johnson BD, Truitt RL.
    Blood; 1995 Jun 01; 85(11):3302-12. PubMed ID: 7756664
    [Abstract] [Full Text] [Related]

  • 2. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD, Drobyski WR, Truitt RL.
    Bone Marrow Transplant; 1993 Apr 01; 11(4):329-36. PubMed ID: 8485480
    [Abstract] [Full Text] [Related]

  • 3. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
    Truitt RL, Atasoylu AA.
    Blood; 1991 Jun 01; 77(11):2515-23. PubMed ID: 2039833
    [Abstract] [Full Text] [Related]

  • 4. Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets.
    Johnson BD, Becker EE, Truitt RL.
    Biol Blood Marrow Transplant; 1999 Jun 01; 5(3):123-32. PubMed ID: 10392958
    [Abstract] [Full Text] [Related]

  • 5. Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells.
    Sefrioui H, Billiau AD, Waer M.
    Transplantation; 2000 Jul 27; 70(2):348-53. PubMed ID: 10933162
    [Abstract] [Full Text] [Related]

  • 6. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR, Majewski D.
    Blood; 1996 Jun 15; 87(12):5355-69. PubMed ID: 8652851
    [Abstract] [Full Text] [Related]

  • 7. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo.
    Johnson BD, Truitt RL.
    Transplantation; 1992 Jul 15; 54(1):104-12. PubMed ID: 1631918
    [Abstract] [Full Text] [Related]

  • 8. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 9. Recipient lymphocyte infusion in MHC-matched bone marrow chimeras induces a limited lymphohematopoietic host-versus-graft reactivity but a significant antileukemic effect mediated by CD8+ T cells and natural killer cells.
    De Somer L, Sprangers B, Fevery S, Rutgeerts O, Lenaerts C, Boon L, Waer M, Billiau AD.
    Haematologica; 2011 Mar 15; 96(3):424-31. PubMed ID: 21109687
    [Abstract] [Full Text] [Related]

  • 10. Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models.
    Vourka-Karussis U, Ackerstein A, Pugatsch T, Slavin S.
    Exp Hematol; 1999 Mar 15; 27(3):461-9. PubMed ID: 10089908
    [Abstract] [Full Text] [Related]

  • 11. Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation.
    Johnson BD, McCabe C, Hanke CA, Truitt RL.
    J Immunol; 1995 May 15; 154(10):5542-54. PubMed ID: 7730653
    [Abstract] [Full Text] [Related]

  • 12. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL, Atasoylu AA.
    Bone Marrow Transplant; 1991 Jul 15; 8(1):51-8. PubMed ID: 1833016
    [Abstract] [Full Text] [Related]

  • 13. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Jul 15; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 14. Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma.
    Truitt RL, Shih CC, LeFever AV.
    Transplantation; 1986 Mar 15; 41(3):301-10. PubMed ID: 3513389
    [Abstract] [Full Text] [Related]

  • 15. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H, Billiau AD, Overbergh L, Rutgeerts O, Waer M.
    Transplantation; 1999 Nov 27; 68(10):1560-7. PubMed ID: 10589955
    [Abstract] [Full Text] [Related]

  • 16. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299.
    Annat J, Churaqui E, Dutartre P, Bruley-Rosset M.
    Transplantation; 1996 Sep 27; 62(6):721-9. PubMed ID: 8824467
    [Abstract] [Full Text] [Related]

  • 17. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
    Aizawa S, Kamisaku H, Sado T.
    Bone Marrow Transplant; 1995 Oct 27; 16(4):603-9. PubMed ID: 8528179
    [Abstract] [Full Text] [Related]

  • 18. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease.
    Waller EK, Ship AM, Mittelstaedt S, Murray TW, Carter R, Kakhniashvili I, Lonial S, Holden JT, Boyer MW.
    Blood; 1999 Nov 01; 94(9):3222-33. PubMed ID: 10556211
    [Abstract] [Full Text] [Related]

  • 19. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr 01; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 20. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.
    J Clin Invest; 1999 Aug 01; 104(3):317-25. PubMed ID: 10430613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.